Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Verona Pharma plc buy Wolfe Research

Start price
€0.51
01.07.25 / 50%
Target price
€144.28
01.07.26
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 01.07.26. The prediction end date can be changed by Wolfe_Research at any time.
Performance without dividends (%)
Name 1w 1m
Verona Pharma plc - -
iShares Core DAX® 0.734% -0.964%
iShares Nasdaq 100 -2.686% -2.409%
iShares Nikkei 225® -2.261% -4.038%
iShares S&P 500 -1.346% -1.510%

Comments by Wolfe_Research for this prediction

In the thread Verona Pharma plc diskutieren
Prediction Buy
Perf. (%) -
Target price 144.279
Change
Ends at 01.07.26

Verona Pharma PLC American Depositary Share (NASDAQ: VRNA) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $170.00 price target on the stock.
Ratings data for VRNA provided by MarketBeat